Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

16.03

-0.17 (-1.05%)

At close: Oct 30, 2026, 4:00 PM EDT

15.98

-0.05 (-0.32%)

After-hours: Oct 30, 2026, 7:56 PM EDT

Summit Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	-	-	-	-	0.71	1.81
Revenue	-	-	-	-	0.71	1.81
Revenue Growth	-	-	-	-	-61.03%	110.35%
Gross Profit	-	-	-	-	0.71	1.81
Selling, General & Admin	306.11	556.75	60.21	29.26	26.74	23.61
Research & Development	568.74	537.67	150.78	59.47	52	85.35
Other Operating Expenses	-	-	-	-	-14.42	-20.97
Operating Expenses	874.84	1,094	210.99	88.74	64.33	88
Operating Income	-874.84	-1,094	-210.99	-88.74	-63.62	-86.19
Interest Expense	-	-	-8.69	-16.46	-4.4	-0.24
Interest & Investment Income	18.9	15.5	13.47	10.4	1.51	-
Currency Exchange Gain (Loss)	-0.64	-0.61	-0.1	1.03	-4.11	-2.14
Other Non Operating Income (Expenses)	0.5	-0.05	-	-0.25	0.3	-0.04
EBT Excluding Unusual Items	-856.09	-1,080	-206.31	-94.01	-70.31	-88.6
Asset Writedown	-	-	-	-	-8.47	-
Pretax Income	-856.09	-1,080	-221.32	-614.93	-78.78	-88.6
Net Income	-856.09	-1,080	-221.32	-614.93	-78.78	-88.6
Net Income to Common	-856.09	-1,080	-221.32	-614.93	-78.78	-88.6
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	766	748	719	620	193	92
Shares Outstanding (Diluted)	766	748	719	620	193	92
Shares Change	4.03%	4.06%	15.96%	220.50%	109.60%	32.67%
EPS (Basic)	-1.12	-1.44	-0.31	-0.99	-0.41	-0.96
EPS (Diluted)	-1.12	-1.44	-0.31	-0.99	-0.41	-0.96
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-459.82	-323.59	-142.25	-76.89	-42.21	-72.89
Free Cash Flow Per Share	-0.60	-0.43	-0.20	-0.12	-0.22	-0.79
Gross Margin	-	-	-	-	100.00%	100.00%
Operating Margin	-	-	-	-	-9024.25%	-4764.29%
Profit Margin	-	-	-	-	-11174.75%	-4897.84%
Free Cash Flow Margin	-	-	-	-	-5986.67%	-4029.46%
EBITDA	-874.67	-1,094	-210.9	-88.54	-62.36	-84.84
D&A For EBITDA	0.17	0.15	0.09	0.2	1.26	1.35
EBIT	-874.84	-1,094	-210.99	-88.74	-63.62	-86.19

SEC Filings: 10-K · 10-Q